omeprazole has been researched along with ascorbic acid in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 12 (44.44) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asaki, S; Ohara, T; Sasaki, R; Shibuya, D; Toyota, T | 1 |
| Reed, PI | 1 |
| Ciofani, G; Cuccurullo, F; de Gioia, S; Festi, D; Lapenna, D | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Groves, FD; Heinrich, JP; Hu, J; Jin, ML; Li, JY; Liu, WD; Ma, JL; Mark, SD; Rabkin, CS; Xu, GW; You, WC; Zhang, L | 1 |
| Carswell, A; McColl, KE; Mowat, C; Wirz, A | 1 |
| Carswell, A; Gillen, D; Gilmour, D; Hossack, M; McColl, KE; Mowat, C; Preston, T; Williams, C; Wirz, A | 1 |
| Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Heinrich, J; Liu, WD; Ma, JL; Xu, GW; Yang, CS; You, WC; Zhang, L | 1 |
| Bavbek, N; Koçkar, C; Oztürk, M | 1 |
| Fukuda, Y; Harada, N; Nawata, H; Ohtani, A; Yoshinaga, M | 1 |
| Chuang, CH; Huang, AH; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Koch, TR; Opara, EC; Petro, A; Yuan, LX | 1 |
| Carswell, A; Fyffe, V; Henry, EB; McColl, KE; Wirz, A | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Hu, Y; Jin, ML; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Xu, GW; You, WC; Zhang, L | 1 |
| Abe, Y; Ara, N; Asanuma, K; Iijima, K; Imatani, A; Ishiyama, F; Koike, T; Ohara, S; Shimosegawa, T; Yoshitake, J | 1 |
| McColl, KE | 1 |
| Derakhshan, F; Haghazali, M; Mirsattari, D; Mohsenian, N; Molaei, M; Talaie, R; Zali, MR; Zojaji, H | 1 |
| Davis, ME; Gaikwad, NW; Lisowyj, MP; Mirvish, SS | 1 |
| Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
| Blot, WJ; Brown, LM; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Han, ZX; Hu, Y; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Shen, L; You, WC; Zhang, L | 1 |
| Ali, ES; Alves, LBDS; Braga, AL; da Mata, AMOF; Das, AK; de Lima, RMT; de Meneses, APM; Dev, S; Dos Reis, AC; E Sousa, JMC; Islam, MT; Khan, IN; Melo-Cavalcante, AAC; Mishra, SK; Mubarak, MS; Paz, MFCJ; Rouf, R; Santos, JVO; Shaw, S; Shil, MC; Shilpi, JA; Uddin, SJ | 1 |
| Braga, AL; Cronemberger, LAC; da Silva, MBS; de Aguiar, RPS; de Alencar, MVOB; de Carvalho, RM; de Lima, RMT; de Meneses, APM; Duarte, JL; Islam, MT; Marcelo de Castro E Sousa, J; Melo-Cavalcante, AAC; Mubarak, MS; Paz, MFCJ | 1 |
| Abed, MN; Alassaf, FA; Alfahad, M; Jasim, MHM; Qazzaz, ME | 1 |
| Braga, AL; de Alencar, MVOB; de Lima, RMT; de Meneses, APM; do Nascimento, PB; Islam, MT; Júnior, ALG; Melo-Cavalcante, AAC; Paz, MFCJ; Santos, JVO; Sousa, JMCE | 1 |
2 review(s) available for omeprazole and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effect of proton pump inhibitors on vitamins and iron.
Topics: Absorption; Ascorbic Acid; Biological Availability; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Omeprazole; Proton Pump Inhibitors; Vitamin B 12; Vitamins | 2009 |
9 trial(s) available for omeprazole and ascorbic acid
| Article | Year |
|---|---|
The ECP-IM intervention study.
Topics: Ascorbic Acid; Clarithromycin; Double-Blind Method; Drug Combinations; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Placebos; Stomach Neoplasms | 1994 |
Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Ascorbic Acid; China; Double-Blind Method; Drug Therapy, Combination; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Penicillins; Phytotherapy; Plant Extracts; Plants, Medicinal; Precancerous Conditions; Selenium; Stomach Neoplasms; Vitamin E | 1998 |
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
Topics: Adult; Aged; Amoxicillin; Antioxidants; Ascorbic Acid; beta Carotene; China; Double-Blind Method; Drug Therapy, Combination; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Phytotherapy; Plants, Medicinal; Precancerous Conditions; Prevalence; Selenium; Stomach Neoplasms; Treatment Outcome; Vitamin E | 2001 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids | 2001 |
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lansoprazole; Male; Metronidazole; Omeprazole; Severity of Illness Index; Stomach Diseases; Treatment Outcome; Vitamin E | 2002 |
Proton pump inhibitors reduce the bioavailability of dietary vitamin C.
Topics: Ascorbic Acid; Biological Availability; Enzyme Inhibitors; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Proton Pump Inhibitors | 2005 |
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Topics: Adult; Amoxicillin; Ascorbic Acid; China; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Garlic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Phytotherapy; Precancerous Conditions; Prevalence; Selenium; Severity of Illness Index; Stomach Neoplasms; Vitamin E | 2006 |
The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Bismuth; Dietary Supplements; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Young Adult | 2009 |
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; China; Confounding Factors, Epidemiologic; Dietary Supplements; Factor Analysis, Statistical; Female; Follow-Up Studies; Garlic; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Omeprazole; Precancerous Conditions; Proportional Hazards Models; Stomach Neoplasms; Vitamin E; Vitamins | 2012 |
16 other study(ies) available for omeprazole and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Effect of omeprazole on ascorbate free radical formation.
Topics: Animals; Ascorbic Acid; Electron Spin Resonance Spectroscopy; Free Radicals; Guinea Pigs; Male; Omeprazole; Oxidation-Reduction | 1992 |
Antioxidant properties of omeprazole.
Topics: Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Chlorides; Copper; Deoxyribose; Ferric Compounds; Hydrogen-Ion Concentration; Hypochlorous Acid; Omeprazole; Oxidation-Reduction | 1996 |
Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice.
Topics: Adult; Anti-Ulcer Agents; Ascorbic Acid; Female; Gastric Acidity Determination; Gastric Juice; Helicobacter pylori; Humans; Male; Middle Aged; Nitrates; Nitrites; Omeprazole | 1999 |
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.
Topics: Adult; Anti-Ulcer Agents; Ascorbic Acid; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbiological Techniques; Middle Aged; Nitrites; Nitrosation; Omeprazole; Saliva | 2000 |
Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy.
Topics: Acids; Anti-Ulcer Agents; Ascorbic Acid; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2001 |
Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion.
Topics: Animals; Antioxidants; Ascorbic Acid; Gastric Emptying; Gastric Mucosa; Glutathione; Lipid Peroxides; Mice; Mice, Inbred Strains; Models, Animal; Omeprazole | 2002 |
Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats.
Topics: Analysis of Variance; Animals; Ascorbic Acid; Biopsy, Needle; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Esophagitis, Peptic; Esophagogastric Junction; Immunohistochemistry; Male; Nitric Oxide; Omeprazole; Peroxidase; Probability; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity | 2009 |
Effect of feeding nitrite, ascorbate, hemin, and omeprazole on excretion of fecal total apparent N-nitroso compounds in mice.
Topics: Animal Feed; Animals; Ascorbic Acid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Feces; Hemin; Male; Meat Products; Mice; Nitroso Compounds; Omeprazole; Sodium Nitrite | 2008 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |
Toxicogenetic study of omeprazole and the modulatory effects of retinol palmitate and ascorbic acid on Allium cepa.
Topics: Allium; Antioxidants; Ascorbic Acid; Diterpenes; DNA Damage; Mutagenesis; Mutagens; Omeprazole; Plant Extracts; Retinyl Esters; Toxicogenetics; Vitamin A | 2018 |
Ascorbic acid and retinol palmitate modulatory effect on omeprazole-induced oxidative damage, and the cytogenetic changes in S. cerevisiae and S180 cells.
Topics: Animals; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Chromosome Aberrations; Cyclophosphamide; Diterpenes; Hydrogen Peroxide; Mice; Micronucleus Tests; Omeprazole; Oxidative Stress; Retinyl Esters; Saccharomyces cerevisiae; Vitamin A | 2019 |
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Esomeprazole; Free Radicals; In Vitro Techniques; Inhibitory Concentration 50; Lansoprazole; Omeprazole; Pantoprazole; Picrates; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry | 2020 |
Antioxidative defense against omeprazole-induced toxicogenetical effects in Swiss mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Comet Assay; Cyclophosphamide; Diterpenes; DNA Repair; Dose-Response Relationship, Drug; Male; Mice; Mutagenesis; Omeprazole; Proton Pump Inhibitors; Retinyl Esters | 2021 |